Tera Novel Overview
Tera Novel develops chemical and biological decontamination products that prevent the spread of viruses (including the novel coronavirus behind COVID-19), infections, and bacteria in hospitals, healthcare facilities, and public institutions. The technology is suitable for incorporation into various products and applications including wall paint, fabrics, coating materials, and polymeric matrices/plastic. The molecule constantly reactivates itself, enabling multiple uses of the application. Tera Novel is a spin-off company from the Israel Institute for Biological Research.
Latest News
growth-positive
Israel makes anti-coronavirus mask from ‘biological warfare’ disinfectant
Hadassah-University Medical Center, in partnership with the Israeli Institute for Biological Research and start-up Tera Novel, has developed a mask that is 99.999% effective in protecting wearers from the coronavirus. The mask, which has been approved by the Health Ministry, uses a technology known as GERMS OVER that was originally developed for the IDF to deal with biological warfare. The mask is now available to the public. Another Israeli company, Sonovia, has also developed a mask, the SonoMask, that has shown an ability to neutralize the coronavirus at an effectiveness of 99.34%. Sonovia recently completed its initial public offering, attracting a total of NIS 55.9 million ($20.4 m.) in investments.
CustomersPartnersPublic TradingExpand
growth-positive
Israeli companies to manufacture anti-coronavirus construction materials
Tera Novel has signed an exclusive strategic cooperation agreement with Tambour, a leading paint and construction material manufacturer in Israel. The partnership aims to produce and market products containing Tera Novels patented antibacterial additive that neutralizes viral compounds such as the coronavirus. The additive, called Germs Over, will be integrated with various construction materials already marketed and manufactured by Tambour. The antibacterial products will be marketed to hospitals, clinics, and health centers. The companies are in advanced discussions with the Health Ministry and various healthcare institutions to introduce their products.
Partners
growth-positive
India to use Israeli solution to safeguard public places in its fight against COVID-19: Report
India will use an antiseptic disinfectant developed by the Israel Institute for Biological Research (IIBR) and distributed by Tera Novel to protect public places against the coronavirus. The solution has been found to disinfect surfaces of bacteria, viruses, molds, and fungi, and remains active for a long time. Tera Novel will transfer the solution to its Indian distributor, Zhiva Innovations Biotech. The technology has undergone successful trials in Israel and is now being used to prevent the spread and infection of the new coronavirus in public institutions. Tera Novel CEO, Keren Cohen Hazon, expressed confidence that the technology will assist India in the fight against the coronavirus.
PartnersCustomers
growth-positive
בלומפילד עבר חיטוי באמצעות חומר חדשני
The Bloomfield stadium in Tel Aviv has undergone innovative disinfection by the TERA NOVEL company and the Biological Institute in Nes Ziona. The new development aims to minimize the risk of infection for players and staff. The unique disinfection material developed by TERA NOVEL eliminates 100% of bacteria, viruses, fungi, and molds and remains effective over time. The technology has also been tested in the Menora Mivtachim Arena for the Maccabi Tel Aviv basketball team. The chairman of the sports company Hapoel Tel Aviv-Yafo praised the comprehensive disinfection and expressed hope for allowing spectators in the future.
Customers
growth-positive
Israeli disinfectant kills 100% of viruses, bacteria
The Israel Institute for Biological Research has developed a disinfectant that kills 100% of bacteria and viruses, including the novel coronavirus. The disinfectant is being distributed by Tera Novel and is currently being used in mikvehs in Bnei Brak, an ultra-Orthodox city in Israel that was severely hit by the virus. The disinfectant was originally developed for and used by the IDF and Israels security forces, and was later transferred for use by the US army. Tera Novel plans to continue providing the disinfectant to other organizations in the public arena.
CustomersExpand
| Sector | Industrial Technologies |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
7
Employees: 1-10
Web & Social Links
| Website | www.teranovel.com/ |
Locations
Yits'har 23, Ramat Hasharon, Israel
Photos & Videos
1 item(s)
Tera Novel Business
Business models
B2C, B2B
Product stage
R&D
Employees
1-10
Sector
Industrial TechnologiesMaterial Innovations & ApplicationsTarget Customer
Real Estate & ConstructionConstructionHealthcare & Life SciencesHealthcareProvidersCore Technology
BiologicalsTags (8)
construction-materialsconstructionhygieneinfectious-diseasedisinfectantshospitalshealthcare-providersbacteriaGeographic Markets
IsraelIndiaTera Novel Financials
Undisclosed
Total funding
—
Capital raised
Undisclosed
Last funding
Pre-Funding
Funding stage
0
Total rounds
0
Investors
Tera Novel Lifecycle
Tera Novel News
5 articles
growth-positive
Israel makes anti-coronavirus mask from ‘biological warfare’ disinfectant
Hadassah-University Medical Center, in partnership with the Israeli Institute for Biological Research and start-up Tera Novel, has developed a mask that is 99.999% effective in protecting wearers from the coronavirus. The mask, which has been approved by the Health Ministry, uses a technology known as GERMS OVER that was originally developed for the IDF to deal with biological warfare. The mask is now available to the public. Another Israeli company, Sonovia, has also developed a mask, the SonoMask, that has shown an ability to neutralize the coronavirus at an effectiveness of 99.34%. Sonovia recently completed its initial public offering, attracting a total of NIS 55.9 million ($20.4 m.) in investments.
CustomersPartnersPublic TradingExpand
growth-positive
Israeli companies to manufacture anti-coronavirus construction materials
Tera Novel has signed an exclusive strategic cooperation agreement with Tambour, a leading paint and construction material manufacturer in Israel. The partnership aims to produce and market products containing Tera Novels patented antibacterial additive that neutralizes viral compounds such as the coronavirus. The additive, called Germs Over, will be integrated with various construction materials already marketed and manufactured by Tambour. The antibacterial products will be marketed to hospitals, clinics, and health centers. The companies are in advanced discussions with the Health Ministry and various healthcare institutions to introduce their products.
Partners
growth-positive
India to use Israeli solution to safeguard public places in its fight against COVID-19: Report
India will use an antiseptic disinfectant developed by the Israel Institute for Biological Research (IIBR) and distributed by Tera Novel to protect public places against the coronavirus. The solution has been found to disinfect surfaces of bacteria, viruses, molds, and fungi, and remains active for a long time. Tera Novel will transfer the solution to its Indian distributor, Zhiva Innovations Biotech. The technology has undergone successful trials in Israel and is now being used to prevent the spread and infection of the new coronavirus in public institutions. Tera Novel CEO, Keren Cohen Hazon, expressed confidence that the technology will assist India in the fight against the coronavirus.
PartnersCustomers
growth-positive
בלומפילד עבר חיטוי באמצעות חומר חדשני
The Bloomfield stadium in Tel Aviv has undergone innovative disinfection by the TERA NOVEL company and the Biological Institute in Nes Ziona. The new development aims to minimize the risk of infection for players and staff. The unique disinfection material developed by TERA NOVEL eliminates 100% of bacteria, viruses, fungi, and molds and remains effective over time. The technology has also been tested in the Menora Mivtachim Arena for the Maccabi Tel Aviv basketball team. The chairman of the sports company Hapoel Tel Aviv-Yafo praised the comprehensive disinfection and expressed hope for allowing spectators in the future.
Customers
growth-positive
Israeli disinfectant kills 100% of viruses, bacteria
The Israel Institute for Biological Research has developed a disinfectant that kills 100% of bacteria and viruses, including the novel coronavirus. The disinfectant is being distributed by Tera Novel and is currently being used in mikvehs in Bnei Brak, an ultra-Orthodox city in Israel that was severely hit by the virus. The disinfectant was originally developed for and used by the IDF and Israels security forces, and was later transferred for use by the US army. Tera Novel plans to continue providing the disinfectant to other organizations in the public arena.
CustomersExpand
Tera Novel Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 3 |
| Team members | 7 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 9 classification IDs that could be used for matching.
Tera Novel Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 88/100 |
| Missing | funding rounds, markets, external profiles, not claimed |
| BI Verification | Hilla Gorokhovsky |
| Registrar ID | 516180536 |
| Creator | Yanina Wainscheinker |
| Creator email | yanina.wain@gmail.com |
| Last updater | Maor Perlov |
| Updater email | maor.perlov@sncentral.org |
| Last update | 2024-03-07T00:00:00.000Z |
| Created | 2020-08-17T00:00:00.000Z |